Naltrexone POA Pharma 50 mg Նորվեգիա - Նորվեգերեն - Statens legemiddelverk

naltrexone poa pharma 50 mg

poa pharma scandinavia ab - naltreksonhydroklorid - tablett, filmdrasjert - 50 mg

Duloxetine Aristo 60 mg Նորվեգիա - Նորվեգերեն - Statens legemiddelverk

duloxetine aristo 60 mg

aristo pharma gmbh - duloksetinhydroklorid - enterokapsel, hard - 60 mg

Duloxetine Aristo 30 mg Նորվեգիա - Նորվեգերեն - Statens legemiddelverk

duloxetine aristo 30 mg

aristo pharma gmbh - duloksetinhydroklorid - enterokapsel, hard - 30 mg

Jorveza Եվրոպական Միություն - Նորվեգերեն - EMA (European Medicines Agency)

jorveza

dr. falk pharma gmbh - budesonide - esophageal sykdommer - antidiarrheals, intestinal betennelsesdempende / antiinfective agents - jorveza er indisert for behandling av eosinofiløsofagitt (eoe) hos voksne (eldre enn 18 år).

Ranivisio Եվրոպական Միություն - Նորվեգերեն - EMA (European Medicines Agency)

ranivisio

midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - Øyemidler - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).

Vantobra (previously Tobramycin PARI) Եվրոպական Միություն - Նորվեգերեն - EMA (European Medicines Agency)

vantobra (previously tobramycin pari)

pari pharma gmbh - tobramycin - respiratory tract infections; cystic fibrosis - antibakterielle midler for systemisk bruk, - vantobra er indisert for behandling av kronisk lunge infeksjon på grunn av pseudomonas aeruginosa hos pasienter i alderen 6 år og voksne med cystisk fibrose (cf). det bør vurderes å offisielle retningslinjer for riktig bruk av antibakterielle midler.

Prialt Եվրոպական Միություն - Նորվեգերեն - EMA (European Medicines Agency)

prialt

esteve pharmaceuticals gmbh - ziconotid - injections, spinal; pain - analgetika - ziconotid er indisert for behandling av alvorlig kronisk smerte hos pasienter som krever intratekal (it) analgesi.

Pirfenidone axunio (previously Pirfenidone AET) Եվրոպական Միություն - Նորվեգերեն - EMA (European Medicines Agency)

pirfenidone axunio (previously pirfenidone aet)

axunio pharma gmbh - pirfenidone - idiopatisk lungefibrose - immunsuppressive - pirfenidone aet is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

Thiotepa Riemser Եվրոպական Միություն - Նորվեգերեն - EMA (European Medicines Agency)

thiotepa riemser

esteve pharmaceuticals gmbh - tiotepa - hematopoietic stem cell transplantation; neoplasms - antineoplastiske midler - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.